210 related articles for article (PubMed ID: 34339730)
21. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
[TBL] [Abstract][Full Text] [Related]
22. Proteome analysis of human CD56
Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L
Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523
[TBL] [Abstract][Full Text] [Related]
23. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.
Mina MM; Cameron B; Luciani F; Vollmer-Conna U; Lloyd AR;
J Viral Hepat; 2016 Jun; 23(6):464-72. PubMed ID: 26833632
[TBL] [Abstract][Full Text] [Related]
26. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.
Capuano C; De Federicis D; Ciuti D; Turriziani O; Angeloni A; Anastasi E; Giannini G; Belardinilli F; Molfetta R; Alvaro D; Palmieri G; Galandrini R
Front Immunol; 2023; 14():1285203. PubMed ID: 38045702
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
29. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
Marcos-Jiménez A; Sánchez-Alonso S; Alcaraz-Serna A; Esparcia L; López-Sanz C; Sampedro-Núñez M; Mateu-Albero T; Sánchez-Cerrillo I; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; Rodríguez-Frade JM; Casasnovas JM; Reyburn HT; Valés-Gómez M; López-Trascasa M; Martín-Gayo E; Calzada MJ; Castañeda S; de la Fuente H; González-Álvaro I; Sánchez-Madrid F; Muñoz-Calleja C; Alfranca A
Eur J Immunol; 2021 Mar; 51(3):634-647. PubMed ID: 33251605
[TBL] [Abstract][Full Text] [Related]
30. Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment.
Ishiyama KI; Kitawaki T; Otsuka Y; Takaori-Kondo A; Kadowaki N
Cancer Sci; 2021 Feb; 112(2):523-536. PubMed ID: 33064914
[TBL] [Abstract][Full Text] [Related]
31. Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients.
Huțanu A; Manu D; Gabor MR; Văsieșiu AM; Andrejkovits AV; Dobreanu M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233174
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
[TBL] [Abstract][Full Text] [Related]
33. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
[TBL] [Abstract][Full Text] [Related]
34. NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
Lee MJ; de Los Rios Kobara I; Barnard TR; Vales Torres X; Tobin NH; Ferbas KG; Rimoin AW; Yang OO; Aldrovandi GM; Wilk AJ; Fulcher JA; Blish CA
J Immunol; 2024 Jun; 212(11):1693-1705. PubMed ID: 38578283
[TBL] [Abstract][Full Text] [Related]
35. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
36. Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients.
Halstead ES; Carcillo JA; Schilling B; Greiner RJ; Whiteside TL
Pediatr Res; 2013 Oct; 74(4):427-32. PubMed ID: 23857294
[TBL] [Abstract][Full Text] [Related]
37. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
Front Immunol; 2021; 12():655934. PubMed ID: 33777054
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
[TBL] [Abstract][Full Text] [Related]
39. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
[TBL] [Abstract][Full Text] [Related]
40. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
